An analysis comparing patients with psoriasis prescribed biologic agents with those prescribed nonbiologic systemic treatments found biologics were associated with a reduced risk for inflammation of the ocular surface and cornea. The How bad was your psoriasis before you went on biologics? : r Psoriasis Skin Manifestations of Diabetes Mellitus Endotext NCBI Bookshelf Psoriasis: What It Is, Causes, Diagnosis & Treatment Real World Canadian Case Series: Use of Tildrakizumab for Moderate to Severe Psoriasis